# GlaxoSmithKline LLC, Durham, NC – FDA Inspections

Source: https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928

> Inspection records and compliance data for GlaxoSmithKline LLC in Durham, North Carolina. 11 FDA inspections on record, last inspected August 16, 2024.

---

## Details

- Name: GlaxoSmithKline LLC
- FEI Number: 1035048
- Address Line 1: 410 Blackwell St
- City: Durham
- State: North Carolina
- Zip Code: 27701
- Country Name: United States
- Address: 410 Blackwell St, Durham, North Carolina 27701, United States
- Country: United States

## Related Documents

- FDA Inspection 1230726 - GlaxoSmithKline LLC - 2024-08-16 — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2024
- FDA Inspection 1103284 - GlaxoSmithKline LLC - 2019-09-12 — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2019
- [EIR - GlaxoSmithKline LLC - 2016-07-15](https://www.keypedia.com/records/eir/glaxosmithkline-llc/be8f57d1-5818-4270-9aa4-bafffac721e9) — source: FDA, date: July 15, 2016
- FDA Inspection 988235 - GlaxoSmithKline LLC - 2016-07-15 — classification: No Action Indicated (NAI), source: FDA, date: July 15, 2016
- [EIR - GlaxoSmithKline LLC - 2015-04-10](https://www.keypedia.com/records/eir/glaxosmithkline-llc/c0defc2a-5c08-451d-97ba-748c53905495) — source: FDA, date: April 10, 2015
- FDA Inspection 921712 - GlaxoSmithKline LLC - 2015-04-10 — classification: No Action Indicated (NAI), source: FDA, date: April 10, 2015
- FDA Inspection 898235 - GlaxoSmithKline LLC - 2014-09-29 — classification: No Action Indicated (NAI), source: FDA, date: September 29, 2014
- FDA Inspection 817398 - GlaxoSmithKline LLC - 2013-02-05 — classification: No Action Indicated (NAI), source: FDA, date: February 5, 2013
- FDA Inspection 817128 - GlaxoSmithKline LLC - 2013-01-31 — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2013
- FDA Inspection 810896 - GlaxoSmithKline LLC - 2012-12-19 — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2012
- [EIR - GlaxoSmithKline LLC - 2012-08-09](https://www.keypedia.com/records/eir/glaxosmithkline-llc/7552b94f-49df-400e-aa75-b62fdb80583f) — source: FDA, date: August 9, 2012
- FDA Inspection 675227 - GlaxoSmithKline LLC - 2010-07-27 — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2010
- FDA Inspection 654076 - GlaxoSmithKline LLC - 2010-02-19 — classification: No Action Indicated (NAI), source: FDA, date: February 19, 2010

## Related Companies

- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/5198bc9c-156b-4adf-ab9d-7ca6271a62bb)
- [Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe](https://www.keypedia.com/companies/caribe-holdings-cayman-co-ltd-dba-puracap-caribe/e746116a-a57b-4872-a647-5ea6d497ff3e)
- [Teva Branded Pharmaceutical Products R&D](https://www.keypedia.com/companies/teva-branded-pharmaceutical-products-rd/7e833f16-5791-422a-944a-bf999e8b8885)
- [Sunandana Chandra, M.D.](https://www.keypedia.com/companies/sunandana-chandra-md/a091d168-e82f-4647-bf29-22c91ba6fc32)
- [Donald J Garcia, Jr. M.D.](https://www.keypedia.com/companies/donald-j-garcia-jr-md/a9185c7c-8af7-4f76-83f6-d313765a3dae)
- [Sant P. Chawla, MD](https://www.keypedia.com/companies/sant-p-chawla-md/12b13bee-4e0f-4d72-a3a7-217e48fb68ef)
- [Takeda Pharmaceuticals USA, Inc.](https://www.keypedia.com/companies/takeda-pharmaceuticals-usa-inc/678d8802-0216-41d5-bdd6-38999c144876)
- [Omega Tech Labs, LLC](https://www.keypedia.com/companies/omega-tech-labs-llc/85cf5888-6344-4179-9b59-4610833d6f11)
- [Corcept Therapeutics Incorporated](https://www.keypedia.com/companies/corcept-therapeutics-incorporated/9f3284cd-b285-4408-818e-19b78043d2e3)
- [Accord Healthcare, Inc.](https://www.keypedia.com/companies/accord-healthcare-inc/3050b4c6-0cc8-4a36-b9c8-12a1f1d03c13)

## Related Officers

- [company_representative](https://www.keypedia.com/people/nicole-taylor/32b3ee89-2da8-40ae-8445-039e844f7b1f)
- [issuing_officer](https://www.keypedia.com/people/nicole-m-bell/56a038c4-9323-43ac-93d7-0b6911286b73)
- [Betsy C. Galliher](https://www.keypedia.com/people/betsy-c-galliher/04add63c-cbcb-42f7-b634-7c2925600bef)
- [company_representative](https://www.keypedia.com/people/thomas-a-lampkin/bb7497cb-629a-42f4-9170-ab77fb023dac)
- [company_representative](https://www.keypedia.com/people/barbara-j-devans/26f4d01e-e0c0-4a8d-8493-f0a5581ad1ed)
- [Commissioned Corps of the U.S. Public Health Service](https://www.keypedia.com/people/adam-r-cooke/337c005d-e9dc-4512-aadb-ee0b0c637bd5)